Therapix Biosciences Fundamental Relationships

TRPX -- Israel Stock  

null 33.70  0.70  2.12%

The Drivers Module shows relationships between Therapix Biosciences's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Therapix Biosciences Ltd over time as well as its relative position and ranking within its peers. Also please take a look at World Market Map.

Therapix Biosciences Beta vs. Current Ratio Fundamental Analysis

Therapix Biosciences Ltd is currently regarded as top stock in current ratio category among related companies. It is rated below average in beta category among related companies .
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Therapix Biosciences 
Current Ratio 
 = 
Current Asset 
Current Liabilities 
=
5.09 times
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e. Current Ration of 2 to 1).
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of financial instrument to the financial market in which this instrument is traded. For example if Beta of equity is 2, it will be expected to significantly outperform market when market is going up and significantly underperform when market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns during over time.
Therapix Biosciences 
Beta 
 = 
Covariance 
Variance 
=
-0.15
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.

Therapix Biosciences Beta Comparison

  Beta 
      Therapix Biosciences Comparables 
Therapix Biosciences is currently under evaluation in beta category among related companies.
  Revenue 
      Therapix Biosciences Comparables 
Therapix Biosciences is currently under evaluation in revenue category among related companies.
Search macroaxis.com